So got a fake crisis, just another flu, Simply not

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks wowhappens28 #35252
218
Quote:
So got a fake crisis, just another flu,


Simply not true, so the entire conspiracy theory you posit falls apart from the falsity of the premise.

Quote:
No, Coronavirus Isn't 'Just Like The Flu'. Here Are The Very Important Differences


https://www.sciencealert.com/the-new-coronavi...-in-common

14 MARCH 2020

Aches and pains, sore throat, fever – although they may feel similar to those suffering from their symptoms, the novel coronavirus is not the same as the seasonal flu, experts stressed Wednesday.

COVID-19, the illness caused by coronavirus, proves deadly in around 3.5 percent of confirmed cases.

While this is not the same as its mortality rate, given many people may be infected but not realise it, it is significantly higher than seasonal flu, which typically kills 0.1 percent of patients.

"There is still considerable uncertainty around the fatality rates of COVID-19 and it likely varies depending on the quality of local healthcare," said Francois Balloux, Professor of Computational Systems Biology at University College London.

"That said, it is around two percent on average, which is about 20 times higher than for the seasonal flu lineages currently in circulation."

Serious cases

But the true danger of coronavirus is unlikely to be the death toll. Experts say health systems could easily become overwhelmed by the number of cases requiring hospitalisation – and, often ventilation to support breathing.

An analysis of 45,000 confirmed cases in China, where the epidemic originated, show that the vast majority of deaths were among the elderly (14.8 percent mortality among over 80s).

But another Chinese study showed that 41 percent of serious cases occurred among under 50s, compared with 27 percent among over 65s.

"It's true that if you're older you're at greater risk, but serious cases can also happen in relatively young people with no prior conditions," said French deputy health minister Jerome Salomon.

Contagiousness

Disease experts estimate that each COVID-19 sufferer infects between two to 3 others.

That's a reproduction rate up to twice as high as seasonal flu, which typically infects 1.3 new people for each patient.


Vaccine/treatment

Salomon said that humans have lived with influenza for more than 100 years.

"We've studied it closely," he said. "This new virus resembles the flu in terms of physical symptoms but there are huge differences."

Number one is the lack of a vaccine against COVID-19, or even any treatment shown to be consistently effective.

While some trials have shown promise delivering anti-retroviral drugs to serious cases, as well as some experimental therapies, their sample sizes are too small to roll out to the general population.

Hundreds of researchers around the world are working frantically to find a COVID-19 vaccine, but the development process takes months and is likely too late for the current outbreak.

Even if a vaccine magically appeared, getting everyone access it to it is no small order. Health authorities regularly complain that not enough people receive the flu vaccine to guarantee "herd immunity".

Similarities

But the new virus does share some characteristics with flu, notably the measures each one of us can personally take to slow the infection rate:

Avoid shaking hands, frequently wash your hands with soap and water, avoid touching your face and wear a mask if you are sick.

Such actions can limit new infections just as they can with the flu, gastro illnesses and other infectious diseases.

France's health ministry says that only two in 10 people regularly wash their hands after using the bathroom.

"And only 42 percent of people cover their mouth with an elbow or tissue when they cough or sneeze," it added, not encouragingly.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infotech's 2026 Report Crowns PSA Software Leaders

Updated Category News Views 20

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 93

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 177

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Updated Category News Views 135

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 93

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 73

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Magnolia Data Breach: Legal Stakes Loom for Seniors

Updated Category News Views 192

Elderly Residents at Risk After Data Breach Well, here we go again — another day, another data breach debacle. This time, it's Magnolia Management putting senior residents' sensitive information on a silver platter for potential cyber intruders. We're talking names, Social Security numbers, and medical records — the whole shebang. When you're handling such crucial...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 23

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 97

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Boldyn Networks Achieves Major Player Status in Private 5G Market

Updated Category News Views 163

Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...

Continue Reading
LinkSquares Debuts All-Agentic CLM Platform for Legal Teams

Updated Category News Views 16

LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...

Continue Reading
Sanctuary Medicinals Triumphs at NECANN Cup with Recognition

Updated Category News Views 216

Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...

Continue Reading
Patients Continue Obesity Treatments as Coverage Shrinks

Updated Category News Views 174

The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...

Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline

Updated Category News Views 123

Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....

Continue Reading